Nevertheless, the full extent of cellular and molecular mechanisms by which the MEK5/ERK5 cascade contributes to colon cancer pathogenesis remains unclear, as does the relevance of this signaling pathway to chemotherapy response. The gene discussed is MAP2K5; the disease is colonic neoplasm.